COVID inequity: In Africa, at-home tests are scarce, costly

February 4, 2022 |
Such a deal! Covid-19 therapies appear cost-effective…for now
Pfizer criticized over patent strategy for Covid-19 pill, despite a deal to broaden access in poor countries
Related Posts
Access to Medicines

Bad Faith from Big Pharma,...
Access to Medicines

Time to Walk Away from the...
Access to Medicines

The Quad TRIPS Waiver Text...